Education
About Us
Working with TipRanks
Follow Us
CV Sciences (CVSI)
:CVSI
Earnings Data
Report Date
May 19, 2025TBA Not Confirmed
Period Ending
2025 (Q1)Consensus EPS Forecast
―Last Year’s EPS
>-0.01Same Quarter Last Year
Based on 0 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Mar 27, 2025
|% Change Since: 0.00%
|Next Earnings Date:May 19, 2025
Earnings Call Sentiment|Neutral
The earnings call highlighted significant efforts in cost reduction and product innovation, with strategic acquisitions contributing to future growth potential. However, the company faces revenue pressure, liquidity challenges, and regulatory uncertainties. Despite these challenges, the company's actions suggest a focus on sustainable growth and efficiency.Company Guidance
During the CV Sciences conference call, management provided guidance for fiscal year 2024, highlighting several key financial metrics and strategic initiatives. The company reported a slight decrease in revenue to $15.7 million from $16 million in 2023, amidst challenging market conditions. However, they achieved an improved gross margin of 45.6%, up from 44.3% the previous year, and reduced operating expenses by 5.4% to $9.4 million. The company emphasized its focus on product innovation, cost efficiency, and strategic acquisitions to drive profitable growth. Notable product launches included the PlusHealth line of cannabinoid-free supplements and the expansion of their Plus CBD pet line. Additionally, CV Sciences undertook two acquisitions—Cultured Foods and Elevated Soft Gels—to enhance their product offerings and achieve greater cost efficiency. The company also entered a strategic relationship with Chewy to bolster their pet product distribution. Despite a GAAP net loss of $0.7 million in Q4 2024, they maintained a stable revenue run rate and improved cash management, reducing operating cash usage significantly from $1.9 million in 2023 to $0.9 million in 2024. The company is optimistic about generating positive cash flow in the second half of 2025, driven by operational synergies from recent acquisitions.Gross Margin Improvement
Gross margin improved to 45.6% in fiscal year 2024, up from 44.3% in 2023, indicating better cost efficiency and product mix.
Successful Product Innovation
Launch of new product lines such as PlusHealth supplements and Plus CBD pet chews, contributing to 28% of the full-year 2024 revenue.
Strategic Acquisitions
Completed two acquisitions, Cultured Foods and Elevated Soft Gels, to expand product lines and increase manufacturing capabilities.
Revenue Stability in Competitive Market
Maintained revenue of $15.7 million in 2024 despite a challenging market, showing resilience compared to competitors facing declines.
Cost Reduction Efforts
Reduced operating expenses by 5.4% in 2024, with ongoing efforts to enhance cost efficiency.
---
CVSI Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
CVSI Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Mar 27, 2025 | $0.03 | $0.03 | 0.00% |
| Nov 14, 2024 | $0.04 | $0.04 | 0.00% |
| Aug 13, 2024 | $0.06 | $0.05 | -16.67% |
| May 14, 2024 | $0.05 | $0.05 | 0.00% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does CV Sciences (CVSI) report earnings?
CV Sciences (CVSI) is schdueled to report earning on May 19, 2025, TBA Not Confirmed.
What is CV Sciences (CVSI) earnings time?
CV Sciences (CVSI) earnings time is at May 19, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is CVSI EPS forecast?
Currently, no data Available
---